Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 20Neoplasms, Plasma Cell 9Pain 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2cyclopia sequence 1Weight Loss 1Thrombocytopenia 1Splenomegaly 1Smoldering Multiple Myeloma 1Neoplasms 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Fever 1Fatigue 1Coronavirus Infections 1Colorectal Neoplasms 1Behavioral Symptoms 1Anosmia 1Anemia 1Amyloidosis 1

Interventions

Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Splenomegaly × Surveys and Questionnaires × Plasma cell × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡